CancerIQ revenue hit $5.5M in 2024

Founder / CEO

Feyi Ayodele

Founder and CEO at Cancer IQ Inc. Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor, and investment banker at McKinsey, Actis LLP, and Credit Suisse respectively. Her journey with Cancer IQ began in 2012, when Feyi wanted to be more of a participant in the healthcare sector than a bystander. On a family trip to climb Mount Kilimanjaro, she hatched a plan to defer her position at McKinsey and commercialize the work of her mother, a renowned medical oncologist. While at University of Chicago Medicine, Feyi witnessed the most cutting edge clinical care, and identified a number of bottlenecks that constrained patient access to it. In 2013, CancerIQ was born. After recruiting a board of thought leading advisors spearheaded by her mother, she led the product design effort, raised capital, and recruited a team to help her flesh-out the concept. Since conceiving the concept, CancerIQ has garnered support from top accelerator programs, investors, and most importantly - customers. She leads the business development team at CancerIQ, and manages all strategic partnerships. She is a Chicago Booth New Venture Challenge winner, a Rock Health fellow, and winner of 1776’s Global Challenge Cup.

Contact via Linkedin Contact via email